Advertisement
GBS Inc. (GBS)
NASDAQ: GBS
· Real-Time Price · USD
0.47
-0.01 (-2.25%)
At close: Oct 27, 2022, 4:00 AM
-2.25% (1D)
| Bid | n/a |
| Market Cap | 433.58K |
| Revenue (ttm) | 2.15M |
| Net Income (ttm) | -15.02M |
| EPS (ttm) | -0.502 |
| PE Ratio (ttm) | -0.9426294820717132 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 9,030 |
| Avg. Volume (20D) | 51,580 |
| Open | 0.48 |
| Previous Close | 0.48 |
| Day's Range | 0.45 - 0.49 |
| 52-Week Range | 0.36 - 2.89 |
| Beta | 0.00 |
About GBS
GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, ho...
Industry Medical - Devices
Sector Healthcare
IPO Date Dec 23, 2020
Employees 12
Stock Exchange NASDAQ
Ticker Symbol GBS
Website https://gbs.inc